清热排脓汤合千金苇茎汤辅助化疗治疗痰瘀互结型肺癌临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R734.2

基金项目:


Clinical Study on Qingre Painong Tang and Qianjin Weijing Tang Combined with Chemotherapy for Lung Cancer of Binding of Phlegm and Stasis Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨清热排脓汤合千金苇茎汤辅助化疗治疗痰瘀互结型肺癌的临床疗效。方法:将 92 例痰瘀互结型肺癌患者按随机数字表法分为研究组和对照组各 46 例。对照组采用紫杉醇与顺铂联合化疗方案治疗,研究组在对照组基础上给予清热排脓汤合千金苇茎汤治疗。观察 2 组临床疗效,比较治疗前后 T 淋巴细胞(CD3+、CD8+、CD4+/CD8+)水平、中医证候积分、生活质量 (FACT-L) 评分、毒副反应发生情况。结果:研究组肿瘤控制率为 84.78%,高于对照组 65.22%,差异有统计学意义(P<0.05)。治疗前,2 组 CD3+、CD8+、CD4+/CD8+水平无明显差异(P>0.05)。治疗后,研究组 CD3+、CD4+/CD8+水平高于治疗前和对照组,CD8+水平低于治疗前和对照组,差异均有统计学意义(P<0.05)。治疗前,2 组中医证候积分比较,差异无统计学意义(P>0.05)。治疗后,2 组中医证候积分较治疗前降低,且研究组中医证候积分低于对照组,差异均有统计学意义(P<0.05)。治疗前,2 组 FACT-L 评分比较,差异无统计学意义 (P>0.05)。治疗后,2 组 FACT-L 评分较治疗前增高,且研究组 FACT-L评分高于对照组,差异均有统计学意义(P<0.05)。研究组血红蛋白减少、白细胞减少、肝肾功能异常、呕吐恶心发生率均低于对照组(P<0.05)。结论:清热排脓汤合千金苇茎汤辅助化疗治疗痰瘀互结型肺癌患者临床疗效确切,可降低中医证候积分,改善免疫功能,提高生活质量,减轻毒副反应。

    Abstract:

    Abstract: Objective: To discuss the clinical effect of Qingre Painong tang and Qianjin Weijing tang combined with chemotherapy for the lung cancer of binding of phlegm and stasis type. Methods:A total of 92 cases of patients with the lung cancer of binding of phlegm and stasis type were divided into the study group and the control group according to the random number table method,46 cases in each group. The control group was given combined chemotherapy regimen with paclitaxel and cisplatin, and the study group was additionally given Qingre Painong tang and Qianjin Weijing tang based on the treatment of the control group. The clinical effect in the two groups was observed. Before and after treatment,the levels of T lymphocytes,namely,CD3+,CD8+ and CD4+/CD8+,Chinese medicine syndrome scores,scores of Functional Assessment of Cancer Treatment- Lung(FACT- L), and the incidence of toxic side effects were compared between the two groups. Results: The tumor control rate was 84.78% in the study group, higher than that of 65.22% in the control group, the difference being significant(P<0.05). Before treatment,when compared the levels of CD3+,CD8+ and CD4+/CD8+ between the two groups,there was no significant difference(P>0.05). After treatment,the levels of CD3+ and CD4+/CD8+ in the study group were higher than those before treatment and in the control group,and the level of CD8 + was lower than that before treatment and that in the control group,differences being significant(P<0.05). Before treatment,when compared Chinese medicine syndrome scores between the two groups,there was no significance in the difference(P>0.05). After treatment, Chinese medicine syndrome scores in the two groups were decreased when compared with those before treatment,and the scores in the study group were lower than those in the control group, differences being significant(P<0.05). Before treatment,when compared scores of FACT-L between the two groups,there was no significance in the difference(P>0.05). After treatment,scores of FACT-L in the two groups were increased when compared with those before treatment,and the score in the study group was higher than that in the control group,differences being significant(P<0.05). The incidence of decreased hemoglobin and leukocytes,dysfunction of the lung and the kidney,as well as vomiting and nausea in the study group was lower than that in the control group(P<0.05). Conclusion:The therapy of Qingre Painong tang and Qianjin Weijing tang combined with chemotherapy has defined clinical effect in treating patients with the lung cancer of binding of phlegm and stasis type,which can reduce Chinese medicine syndrome scores,improve immune function,promote the quality of life, and alleviate toxic side effects.

    参考文献
    相似文献
    引证文献
引用本文

刘东虎,张涛,廖校贤,胡群峰.清热排脓汤合千金苇茎汤辅助化疗治疗痰瘀互结型肺癌临床研究[J].新中医,2020,52(22):104-108

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-11-27
  • 出版日期:
文章二维码